Clinical Trial

Mindfulness-based Neurofeedback to Reduce Negative Thinking in CHARMS Adolescents

Study acronym: CHARMS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study will test the hypothesis that mindfulness-based neurofeedback (mbNF) will improve repetitive negative thinking and social and role functioning over sham neurofeedback in adolescents at risk for serious mental illness. To do so, 90 adolescents ages 14-21 with elevated repetitive negative thinking will be enrolled into a double-blind randomized clinical trial of sessions of mindfulness training with either active mindfulness-based neurofeedback or sham neurofeedback and three months of mindfulness practice and follow up.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-27.
Trial Details
NCT Number NCT06901232
Lead Sponsor Massachusetts General Hospital
Conditions Repetitive Negative Thinking, Serious Mental Illness Symptoms
Enrollment 90 participants
Start Date 2027-09
Primary Completion 2029-04 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-12